AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 84 filers reported holding AVADEL PHARMACEUTICALS PLC in Q2 2021. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $111 | -68.4% | 12,166 | -75.2% | 0.00% | – |
Q4 2022 | $351 | -100.0% | 49,096 | -66.1% | 0.00% | -100.0% |
Q3 2022 | $726,000 | +109.2% | 144,957 | +1.7% | 0.00% | – |
Q2 2022 | $347,000 | -65.2% | 142,577 | -2.4% | 0.00% | -100.0% |
Q1 2022 | $998,000 | -21.6% | 146,142 | -7.3% | 0.00% | 0.0% |
Q4 2021 | $1,273,000 | +121.8% | 157,637 | +168.7% | 0.00% | 0.0% |
Q3 2021 | $574,000 | +144.3% | 58,672 | +67.8% | 0.00% | – |
Q2 2021 | $235,000 | -25.6% | 34,970 | 0.0% | 0.00% | – |
Q1 2021 | $316,000 | +58.8% | 34,970 | +17.1% | 0.00% | – |
Q4 2020 | $199,000 | +4875.0% | 29,860 | +4876.7% | 0.00% | – |
Q1 2018 | $4,000 | 0.0% | 600 | 0.0% | 0.00% | – |
Q4 2017 | $4,000 | 0.0% | 600 | +50.0% | 0.00% | – |
Q3 2017 | $4,000 | – | 400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WEALTH EFFECTS LLC | 2,409,289 | $24,815,676 | 12.25% |
Knoll Capital Management, LLC | 600,000 | $6,180,000 | 6.42% |
Vivo Capital, LLC | 4,096,428 | $42,193,208 | 4.62% |
GENDELL JEFFREY L | 5,615,350 | $57,838,105 | 3.29% |
Tri Locum Partners LP | 983,602 | $10,131,101 | 3.24% |
Samsara BioCapital, LLC | 967,527 | $9,965,528 | 3.05% |
MPM BioImpact LLC | 664,224 | $6,841,507 | 1.83% |
COWEN AND COMPANY, LLC | 2,338,302 | $24,084,510 | 1.68% |
RTW INVESTMENTS, LP | 7,136,415 | $73,505,075 | 1.55% |
TANG CAPITAL MANAGEMENT LLC | 1,000,000 | $10,300,000 | 1.45% |